Overbrook Management Corp Sells 951 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Overbrook Management Corp lowered its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 3.2% during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 28,832 shares of the healthcare conglomerate's stock after selling 951 shares during the quarter. UnitedHealth Group accounts for about 3.9% of Overbrook Management Corp's portfolio, making the stock its 10th biggest position. Overbrook Management Corp's holdings in UnitedHealth Group were worth $16,858,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also bought and sold shares of UNH. China Universal Asset Management Co. Ltd. grew its stake in UnitedHealth Group by 20.6% in the first quarter. China Universal Asset Management Co. Ltd. now owns 10,867 shares of the healthcare conglomerate's stock valued at $5,376,000 after purchasing an additional 1,857 shares in the last quarter. Quent Capital LLC grew its stake in UnitedHealth Group by 5.5% in the first quarter. Quent Capital LLC now owns 4,196 shares of the healthcare conglomerate's stock valued at $2,076,000 after purchasing an additional 217 shares in the last quarter. EntryPoint Capital LLC bought a new position in UnitedHealth Group in the first quarter valued at approximately $75,000. Rodgers Brothers Inc. boosted its stake in shares of UnitedHealth Group by 2.4% during the 1st quarter. Rodgers Brothers Inc. now owns 842 shares of the healthcare conglomerate's stock worth $417,000 after acquiring an additional 20 shares during the period. Finally, Guardian Capital LP boosted its stake in shares of UnitedHealth Group by 0.9% during the 1st quarter. Guardian Capital LP now owns 56,015 shares of the healthcare conglomerate's stock worth $27,711,000 after acquiring an additional 477 shares during the period. Institutional investors and hedge funds own 87.86% of the company's stock.

UnitedHealth Group Stock Performance

Shares of UnitedHealth Group stock opened at $600.50 on Thursday. The company has a market cap of $552.63 billion, a PE ratio of 39.12, a price-to-earnings-growth ratio of 1.69 and a beta of 0.58. UnitedHealth Group Incorporated has a 52 week low of $436.38 and a 52 week high of $630.73. The business has a 50 day moving average price of $582.52 and a 200-day moving average price of $551.60. The company has a quick ratio of 0.91, a current ratio of 0.91 and a debt-to-equity ratio of 0.74.

UnitedHealth Group (NYSE:UNH - Get Free Report) last issued its quarterly earnings data on Tuesday, October 15th. The healthcare conglomerate reported $7.15 EPS for the quarter, topping the consensus estimate of $7.00 by $0.15. The firm had revenue of $100.82 billion during the quarter, compared to the consensus estimate of $99.14 billion. UnitedHealth Group had a return on equity of 26.37% and a net margin of 3.63%. The company's quarterly revenue was up 9.2% compared to the same quarter last year. During the same period in the prior year, the business posted $6.56 earnings per share. Equities analysts anticipate that UnitedHealth Group Incorporated will post 27.6 earnings per share for the current fiscal year.

UnitedHealth Group Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, December 17th. Investors of record on Monday, December 9th will be given a dividend of $2.10 per share. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.40%. The ex-dividend date is Monday, December 9th. UnitedHealth Group's payout ratio is 54.72%.

Analyst Upgrades and Downgrades

Several research analysts have recently commented on UNH shares. TD Cowen lifted their target price on UnitedHealth Group from $601.00 to $609.00 and gave the stock a "buy" rating in a research note on Friday, October 18th. HSBC downgraded UnitedHealth Group from a "buy" rating to a "hold" rating in a research note on Thursday, October 17th. Truist Financial restated a "buy" rating and issued a $625.00 price target (down from $640.00) on shares of UnitedHealth Group in a research note on Wednesday, October 16th. Barclays reduced their price target on UnitedHealth Group from $604.00 to $603.00 and set an "overweight" rating for the company in a research note on Tuesday, October 22nd. Finally, Bank of America reduced their price target on UnitedHealth Group from $675.00 to $650.00 and set a "buy" rating for the company in a research note on Wednesday, October 16th. Four investment analysts have rated the stock with a hold rating, seventeen have given a buy rating and two have given a strong buy rating to the stock. According to MarketBeat.com, the stock has an average rating of "Moderate Buy" and a consensus target price of $615.53.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.